title: Urocortin 1 modulates immunosignaling in a rat model of colitis via corticotropin-releasing factor receptor 2.
abstract: Urocortins (UCNs) and their receptors are potent immunoregulators in the gastrointestinal (GI) tract, where they can exert both pro- and anti-inflammatory effects. We examined the contribution of Ucn1 and its receptors to the pathogenesis, progression, and resolution of colitis. Trinitrobenzene sulfonic acid was used to induce colitis in rats. Ucn1 mRNA and immunoreactivity (IR) were ubiquitously expressed throughout the GI tract under basal conditions. During colitis, Ucn1 mRNA levels fell below basal levels on day 1 then increased again by day 6, in association with an increase in the number of Ucn1-IR inflammatory cells. Ucn1-IR cells were also numerous in proliferating granulation tissue. In contrast to Ucn1 expression, average phosphorylated ERK1/2 (pERK1/2) expression rose above controls levels on day 1 and was very low on day 6 of colitis. Knockdown of corticotropin-releasing factor 2 (CRF(2)) but not CRF(1) by RNA interference during colitis significantly decreased the macroscopic lateral spread of ulceration compared with uninjected controls or animals with CRF(1) knockdown. After knockdown of CRF(2), but not of CRF(1) during colitis, edema resolution assessed microscopically was slowed, and myeloperoxidase activity remained elevated even at day 6. Ucn1 and TNF-α mRNA peaked earlier, whereas pERK1/2 activation was attenuated after CRF(2) knockdown. Thus we conclude that local CRF(2) and pERK1/2 activation is pivotal for macroscopic spread of colitis and resolution of edema. Elimination of CRF(2), but not CRF(1), results in uncoordinated immune and pERK1/2 signaling responses.
authors.affiliation: Dept. of Surgery, Univ. of California, San Francisco, 94143-0660, USA.
authors.forename: Jen
authors.initials: J
authors.lastname: Chang
authors.forename: Melanie R
authors.initials: MR
authors.lastname: Adams
authors.forename: Matthew S
authors.initials: MS
authors.lastname: Clifton
authors.forename: Min
authors.initials: M
authors.lastname: Liao
authors.forename: Julia H
authors.initials: JH
authors.lastname: Brooks
authors.forename: Burcu
authors.initials: B
authors.lastname: Hasdemir
authors.forename: Aditi
authors.initials: A
authors.lastname: Bhargava
mesh_terms: D000818:Animals; D015153:Blotting, Western; D003092:Colitis / Q000276:immunology / Q000473:pathology / Q000503:physiopathology*; D018450:Disease Progression; D004487:Edema / Q000209:etiology / Q000473:pathology; D048049:Extracellular Signal-Regulated MAP Kinases / Q000502:physiology; D007150:Immunohistochemistry; D007700:Kinetics; D008297:Male; D009195:Peroxidase / Q000378:metabolism; D010766:Phosphorylation; D034622:RNA Interference; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D018019:Receptors, Corticotropin-Releasing Hormone / Q000502:physiology*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction / Q000502:physiology; D014302:Trinitrobenzenesulfonic Acid; D054832:Urocortins / Q000502:physiology*; D000099052:CRF Receptor, Type 1
chemical_list: C101531:CRF receptor type 2; D012333:RNA, Messenger; D018019:Receptors, Corticotropin-Releasing Hormone; D054832:Urocortins; D000099052:CRF Receptor, Type 1; D014302:Trinitrobenzenesulfonic Acid; D009195:Peroxidase; D048049:Extracellular Signal-Regulated MAP Kinases